1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)

Chiari, R., Ricciuti, B., Landi, L., Morelli, A. M., Delmonte, A., Spitaleri, G., Cortinovis, D. L., Lamberti, G., Facchinetti, F., Pilotto, S., Verusio, C., Chella, A., Bonanno, L., Galetta, D. & Cappuzzo, F., Jan 2020, In : Clinical Lung Cancer. 21, 1, p. 15-20 6 p.

Research output: Contribution to journalArticle

ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)

Chiari, R., Ricciuti, B., Landi, L., Morelli, A. M., Delmonte, A., Spitaleri, G., Cortinovis, D. L., Lamberti, G., Facchinetti, F., Pilotto, S., Verusio, C., Chella, A., Bonanno, L., Galetta, D. & Cappuzzo, F., Jan 1 2020, In : Clin. Lung Cancer. 21, 1, p. 15-20 6 p.

Research output: Contribution to journalArticle

2019

Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients.

Reale, M. L., Chiari, R., Tiseo, M., Vitiello, F., Barbieri, F., Cortinovis, D., Ceresoli, G. L., Finocchiaro, G., Romano, G. D., Piovano, P. L., Del Conte, A., Borra, G., Verderame, F., Scotti, V., Nonnis, D., Galetta, D., Sergi, C., Migliorino, M. R., Tonini, G., Cecere, F. & 11 others, Berardi, R., Pino, M. S., Martelli, O., Gelibter, A., Carta, A., Vattemi, E., Pagano, M., Zullo, A., Ferrari, S., Rossi, A. & Novello, S., Dec 16 2019, In : Lung Cancer.

Research output: Contribution to journalArticle

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Landi, L., D'Incà, F., Gelibter, A., Chiari, R., Grossi, F., Delmonte, A., Passaro, A., Signorelli, D., Gelsomino, F., Galetta, D., Giannarelli, D., Soto Parra, H., Minuti, G., Tiseo, M., Migliorino, M. R., Cognetti, F., Toschi, L., Bidoli, P., Piantedosi, F., Calabro', L. & 1 others, Cappuzzo, F., Nov 21 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 316.

Research output: Contribution to journalArticle

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer: Journal for ImmunoTherapy of Cancer

Landi, L., D'Incà, F., Gelibter, A., Chiari, R., Grossi, F., Delmonte, A., Passaro, A., Signorelli, D., Gelsomino, F., Galetta, D., Giannarelli, D., Soto Parra, H., Minuti, G., Tiseo, M., Migliorino, M. R., Cognetti, F., Toschi, L., Bidoli, P., Piantedosi, F., Calabro', L. & 1 others, Cappuzzo, F., 2019, In : J. Immunother. Cancer. 7, 1

Research output: Contribution to journalArticle

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

Landi, L., D'Incà, F., Gelibter, A., Chiari, R., Grossi, F., Delmonte, A., Passaro, A., Signorelli, D., Gelsomino, F., Galetta, D., Giannarelli, D., Soto Parra, H., Minuti, G., Tiseo, M., Migliorino, M. R., Cognetti, F., Toschi, L., Bidoli, P., Piantedosi, F., Calabro', L. & 1 others, Cappuzzo, F., 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1

Research output: Contribution to journalArticle

BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience

Rihawi, K., Giannarelli, D., Galetta, D., Delmonte, A., Giavarra, M., Turci, D., Garassino, M., Tiseo, M., Barbieri, F., Panni, S. & Ardizzoni, A., Mar 2019, In : Journal of Thoracic Oncology. 14, 3, p. e57-e59

Research output: Contribution to journalLetter

Breath analysis: A systematic review of Volatile Organic Compounds (VOCs) in diagnostic and therapeutic management of pleural mesothelioma

Catino, A., de Gennaro, G., Di Gilio, A., Facchini, L., Galetta, D., Palmisani, J., Porcelli, F. & Varesano, N., Jun 2019, In : Cancers. 11, 6, E831.

Research output: Contribution to journalReview article

Open Access

Crizotinib in MET-deregulated or ROS1-rearranged pretreated non–small cell lung cancer (METROS): A phase II, prospective, multicenter, two-arms trial

Landi, L., Chiari, R., Tiseo, M., D'Inca, F., Dazzi, C., Chella, A., Delmonte, A., Bonanno, L., Giannarelli, D., Cortinovis, D. L., de Marinis, F., Borra, G., Morabito, A., Gridelli, C., Galetta, D., Barbieri, F., Grossi, F., Capelletto, E., Minuti, G., Mazzoni, F. & 8 others, Verusio, C., Bria, E., Al, G., Bruno, R., Proietti, A., Fontanini, G., Crino, L. & Cappuzzo, F., 2019, In : Clinical Cancer Research. 25, 24, p. 7312-7319 8 p.

Research output: Contribution to journalArticle

Crizotinib in MET-deregulated or ROS1-rearranged pretreated non–small cell lung cancer (METROS): A phase II, prospective, multicenter, two-arms trial: Clinical Cancer Research

Landi, L., Chiari, R., Tiseo, M., D'Inca, F., Dazzi, C., Chella, A., Delmonte, A., Bonanno, L., Giannarelli, D., Cortinovis, D. L., de Marinis, F., Borra, G., Morabito, A., Gridelli, C., Galetta, D., Barbieri, F., Grossi, F., Capelletto, E., Minuti, G., Mazzoni, F. & 8 others, Verusio, C., Bria, E., Al, G., Bruno, R., Proietti, A., Fontanini, G., Crino, L. & Cappuzzo, F., 2019, In : Clin. Cancer Res.. 25, 24, p. 7312-7319 8 p.

Research output: Contribution to journalArticle

Crizotinib in MET deregulated or ROS1 rearranged pretreated non-small-cell lung cancer (METROS): a phase II, prospective, multicentre, two-arms trial

Landi, L., Chiari, R., Tiseo, M., D'Incà, F., Dazzi, C., Chella, A., Delmonte, A., Bonanno, L., Giannarelli, D., Cortinovis, D. L., De Marinis, F., Borra, G., Morabito, A., Gridelli, C., Galetta, D., Barbieri, F., Grossi, F., Capelletto, E., Minuti, G., Mazzoni, F. & 8 others, Verusio, C., Bria, E., Alì, G., Bruno, R., Proietti, A., Fontanini, G., Crinò, L. & Cappuzzo, F., 2019, In : Clin. Cancer Res.. 25, 24, p. 7312-7319 8 p.

Research output: Contribution to journalArticle

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

Passiglia, F., Cappuzzo, F., Alabiso, O., Bettini, A. C., Bidoli, P., Chiari, R., Defferrari, C., Delmonte, A., Finocchiaro, G., Francini, G., Gelsomino, F., Giannarelli, D., Giordano, M., Illiano, A., Livi, L., Martelli, O., Natoli, C., Puppo, G., Ricevuto, E., Roca, E. & 2 others, Turci, D. & Galetta, D., Jan 8 2019, In : British Journal of Cancer. 120, 1, p. 57-62 6 p.

Research output: Contribution to journalArticle

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population

Crinò, L., Bidoli, P., Delmonte, A., Grossi, F., De Marinis, F., Ardizzoni, A., Vitiello, F., Lo Russo, G., Parra, H. S., Cortesi, E., Cappuzzo, F., Calabrò, L., Tiseo, M., Turci, D., Gamucci, T., Antonelli, P., Morabito, A., Chella, A., Giannarelli, D. & Galetta, D., Nov 1 2019, In : Oncologist. 24, 11, p. e1165-e1171

Research output: Contribution to journalArticle

Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population

Crinò, L., Bidoli, P., Delmonte, A., Grossi, F., De Marinis, F., Ardizzoni, A., Vitiello, F., Lo Russo, G., Parra, H. S., Cortesi, E., Cappuzzo, F., Calabrò, L., Tiseo, M., Turci, D., Gamucci, T., Antonelli, P., Morabito, A., Chella, A., Giannarelli, D. & Galetta, D., 2019, In : Oncologist. 24, 11, p. e1165-e1171

Research output: Contribution to journalArticle

Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial

On behalf of the Italian association FONICAP (Operative National Interdisciplinary Force against Lung Cancer), Aug 1 2019, In : Lung Cancer. 134, p. 121-126 6 p.

Research output: Contribution to journalArticle

Open Access

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes

Cortellini, A., Leonetti, A., Catino, A., Pizzutillo, P., Ricciuti, B., De Giglio, A., Chiari, R., Bordi, P., Santini, D., Giusti, R., De Tursi, M., Brocco, D., Zoratto, F., Rastelli, F., Citarella, F., Russano, M., Filetti, M., Marchetti, P., Berardi, R., Torniai, M. & 17 others, Cortinovis, D., Sala, E., Maggioni, C., Follador, A., Macerelli, M., Nigro, O., Tuzi, A., Iacono, D., Migliorino, M. R., Banna, G., Porzio, G., Cannita, K., Ferrara, M. G., Bria, E., Galetta, D., Ficorella, C. & Tiseo, M., Jan 1 2019, In : Clinical and Translational Oncology.

Research output: Contribution to journalArticle

Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 ≥50% who progress on first-line immunotherapy: Real-world data from a European cohort

Metro, G., Addeo, A., Signorelli, D., Gili, A., Economopoulou, P., Roila, F., Banna, G., De Toma, A., Cobo, J. R., Camerini, A., Christopoulou, A., Russo, G. L., Banini, M., Galetta, D., Jimenez, B., Collazo-Lorduy, A., Calles, A., Baxevanos, P., Linardou, H., Kosmidis, P. & 2 others, Garassino, M. C. & Mountzios, G., Dec 1 2019, In : Journal of Thoracic Disease. 11, 12, p. 4972-4981 10 p.

Research output: Contribution to journalArticle

Peripheral blood biomarkers as prognostic factors for immunotherapy in advanced non-small cell lung cancer (aNSCLC) patients

Prelaj, A., Rebuzzi, S. E., Pizzutilo, P., Bilancia, M., Montrone, M., Pesola, F., Longo, V., Del Bene, G., Lapadula, V., Cassano, F., Petrillo, P., Bafunno, D., Varesano, N., Lamorgese, V., Mastranrdea, A., Ricci, D., Catino, A. & Galetta, D., Apr 2019, In : Annals of Oncology. 30, p. ii58

Research output: Contribution to journalArticle

Open Access

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study

Gobbini, E., Chiari, R., Pizzutillo, P., Bordi, P., Ghilardi, L., Pilotto, S., Osman, G., Cappuzzo, F., Cecere, F., Riccardi, F., Scotti, V., Martelli, O., Borra, G., Maiello, E., Rossi, A., Graziano, P., Gregorc, V., Casartelli, C., Sergi, C., Del Conte, A. & 11 others, Delmonte, A., Bareggi, C., Cortinovis, D., Rizzo, P., Tabbò, F., Rossi, G., Bria, E., Galetta, D., Tiseo, M., Di Maio, M. & Novello, S., Oct 19 2019, In : Clinical and Translational Oncology. p. 10.1007/s12094-019-02222-8 8 p.

Research output: Contribution to journalArticle

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study

Gobbini, E., Chiari, R., Pizzutillo, P., Bordi, P., Ghilardi, L., Pilotto, S., Osman, G., Cappuzzo, F., Cecere, F., Riccardi, F., Scotti, V., Martelli, O., Borra, G., Maiello, E., Rossi, A., Graziano, P., Gregorc, V., Casartelli, C., Sergi, C., Del Conte, A. & 11 others, Delmonte, A., Bareggi, C., Cortinovis, D., Rizzo, P., Tabbò, F., Rossi, G., Bria, E., Galetta, D., Tiseo, M., Di Maio, M. & Novello, S., 2019, In : Clinical and Translational Oncology.

Research output: Contribution to journalArticle

Open Access

The presence of concomitant mutations affects the activity of egfr tyrosine kinase inhibitors in egfr-mutant non-small cell lung cancer (Nsclc) patients

Rachiglio, A. M., Fenizia, F., Piccirillo, M. C., Galetta, D., Crinò, L., Vincenzi, B., Barletta, E., Pinto, C., Ferraù, F., Lambiase, M., Montanino, A., Roma, C., Ludovini, V., Montagna, E. S., Luca, A. D., Rocco, G., Botti, G., Perrone, F., Morabito, A. & Normanno, N., Mar 10 2019, In : Cancers. 11, 3, 341.

Research output: Contribution to journalArticle

Open Access

Time-series of peripheral blood biomarkers as biomarkers for immunotherapy in advanced non-small cell lung cancer (aNSCLC) patients

Prelaj, A., Rebuzzi, S. E., Pizzutilo, P., Bilancia, M., Montrone, M., Pesola, F., Longo, V., Del Bene, G., Lapadula, V., Cassano, F., Petrillo, P., Bafunno, D., Varesano, N., Lamorgese, V., Mastranrdea, A., Ricci, D., Catino, A. & Galetta, D., Apr 2019, In : Annals of Oncology. 30, p. ii34

Research output: Contribution to journalArticle

Open Access

Tobacco control in Europe: A review of campaign strategies for teenagers and adults

Bafunno, D., Catino, A., Lamorgese, V., Pizzutilo, P., Di Lauro, A., Petrillo, P., Lapadula, V., Mastrandrea, A., Ricci, D. & Galetta, D., Jun 2019, In : Critical Reviews in Oncology/Hematology. 138, p. 139-147 9 p.

Research output: Contribution to journalReview article

2018

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

Metro, G., Passaro, A., Lo Russo, G., Bonanno, L., Giusti, R., Gregorc, V., Capelletto, E., Martelli, O., Cecere, F. L., Giannarelli, D., Luciani, A., Bearz, A., Tuzi, A., Scotti, V., Tonini, G., Galetta, D., Carta, A., Soto Parra, H., Rebonato, A., Morabito, A. & 1 others, Chiari, R., Feb 1 2018, In : Future Oncology. 14, 4, p. 353-361 9 p.

Research output: Contribution to journalArticle

Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey

Carnio, S., Galetta, D., Scotti, V., Cortinovis, D. L., Antonuzzo, A., Pisconti, S., Rossi, A., Martelli, O., Cecere, F. L., Lunghi, A., Del Conte, A., Montagna, E. S., Topulli, J., Pelizzoni, D., Rapetti, S. G., Gianetta, M., Pacchiana, M. V., Pegoraro, V., Cataldo, N., Bria, E. & 1 others, Novello, S., Jun 1 2018, In : Supportive Care in Cancer. 26, 6, p. 1841-1849 9 p.

Research output: Contribution to journalArticle

Final data of an Italian multicentric survey about counseling for smoking cessation in patients with diagnosis of a respiratory disease

Capelletto, E., Rapetti, S. G., Demichelis, S., Galetta, D., Catino, A., Ricci, D., Moretti, A. M., Bria, E., Pilotto, S., Bruno, A., Valmadre, G., Bandelli, G. P., Trisolini, R., Gianetta, M., Pacchiana, M. V., Vallone, S. & Novello, S., Mar 1 2018, In : Clinical Respiratory Journal. 12, 3, p. 1150-1159 10 p.

Research output: Contribution to journalArticle

Italian Nivolumab Expanded Access Program in Nonsquamous Non–Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients

Garassino, M. C., Gelibter, A. J., Grossi, F., Chiari, R., Soto Parra, H., Cascinu, S., Cognetti, F., Turci, D., Blasi, L., Bengala, C., Mini, E., Baldini, E., Quadrini, S., Ceresoli, G. L., Antonelli, P., Vasile, E., Pinto, C., Fasola, G., Galetta, D., Macerelli, M. & 3 others, Giannarelli, D., Lo Russo, G. & de Marinis, F., Aug 1 2018, In : Journal of Thoracic Oncology. 13, 8, p. 1146-1155 10 p.

Research output: Contribution to journalArticle

Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients

Garassino, M. C., Gelibter, A. J., Grossi, F., Chiari, R., Soto Parra, H., Cascinu, S., Cognetti, F., Turci, D., Blasi, L., Bengala, C., Mini, E., Baldini, E., Quadrini, S., Ceresoli, G. L., Antonelli, P., Vasile, E., Pinto, C., Fasola, G., Galetta, D., Macerelli, M. & 3 others, Giannarelli, D., Lo Russo, G. & de Marinis, F., Aug 2018, In : Journal of Thoracic Oncology. 13, 8, p. 1146-1155 10 p.

Research output: Contribution to journalArticle

2017

Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study

Migliorino, M. R., Santo, A., Romano, G., Cortinovis, D., Galetta, D., Alabiso, O., Cartenì, G., Vari, S., Fasola, G., Pazzola, A., Giuffrida, D., Zaniboni, A., Caprioli, A., Longo, F., Acciai, V. & de Marinis, F., May 1 2017, In : Journal of Cancer Research and Clinical Oncology. 143, 5, p. 783-791 9 p.

Research output: Contribution to journalArticle

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer

Gobbini, E., Pilotto, S., Pasello, G., Polo, V., Di Maio, M., Arizio, F., Galetta, D., Petrillo, P., Chiari, R., Matocci, R., Di Costanzo, A., Di Stefano, T. S., Aglietta, M., Cagnazzo, C., Sperduti, I., Bria, E. & Novello, S., 2017, In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non–Small-cell Lung Cancer: A Systematic Review and Meta-analysis

La Salvia, A., Rossi, A., Galetta, D., Gobbini, E., De Luca, E., Novello, S. & Di Maio, M., Jan 1 2017, In : Clinical Lung Cancer. 18, 1, p. 23-33 11 p.

Research output: Contribution to journalReview article

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study

Gobbini, E., Galetta, D., Tiseo, M., Graziano, P., Rossi, A., Bria, E., Di Maio, M., Rossi, G., Gregorc, V., Riccardi, F., Scotti, V., Ceribelli, A., Buffoni, L., Delmonte, A., Franchina, T., Migliorino, M. R., Cortinovis, D., Pisconti, S., Bordi, P., Catino, A. & 3 others, Maiello, E., Arizio, F. & Novello, S., Sep 1 2017, In : Lung Cancer. 111, p. 30-37 8 p.

Research output: Contribution to journalArticle

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study

Gobbini, E., Galetta, D., Tiseo, M., Graziano, P., Rossi, A., Bria, E., Di Maio, M., Rossi, G., Gregorc, V., Riccardi, F., Scotti, V., Ceribelli, A., Buffoni, L., Delmonte, A., Franchina, T., Migliorino, M. R., Cortinovis, D., Pisconti, S., Bordi, P., Catino, A. & 4 others, Maiello, E., Arizio, F., Novello, S. & Co-Authors, O. B. O. O., 2017, In : Lung Cancer. 111, 6, p. 30-37 8 p.

Research output: Contribution to journalArticle

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study

Gobbini, E., Galetta, D., Tiseo, M., Graziano, P., Rossi, A., Bria, E., Di Maio, M., Rossi, G., Gregorc, V., Riccardi, F., Scotti, V., Ceribelli, A., Buffoni, L., Delmonte, A., Franchina, T., Migliorino, M. R., Cortinovis, D., Pisconti, S., Bordi, P., Catino, A. & 3 others, Maiello, E., Arizio, F. & Novello, S., 2017, In : Lung Cancer. 111, p. 30-37 8 p.

Research output: Contribution to journalArticle

Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study

Pilotto, S., Rossi, A., Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C. & 9 others, Filipazzi, V., Menis, J., Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Spitaleri, G., Bria, E. & Novello, S., 2017, In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

2016

A phase 2 randomized study of TAS-102 versus topotecan or amrubicin in patients requiring second-line chemotherapy for small cell lung cancer refractory or sensitive to frontline platinum-based chemotherapy

Scagliotti, G., Nishio, M., Satouchi, M., Valmadre, G., Niho, S., Galetta, D., Cortinovis, D., Benedetti, F., Yoshihara, E., Makris, L., Inoue, A. & Kubota, K., Oct 1 2016, In : Lung Cancer. 100, 1, p. 20-23 4 p.

Research output: Contribution to journalArticle

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.

Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D. L., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C., Filipazzi, V., Menis, J. & 8 others, Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Bria, E., Spitaleri, G., Rossi, A. & Novello, S., May 1 2016, In : Lung Cancer. 95, p. 73-81 9 p.

Research output: Contribution to journalArticle

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.

Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D. L., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C., Filipazzi, V., Menis, J. & 8 others, Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Bria, E., Spitaleri, G., Rossi, A. & Novello, S., May 1 2016, In : Lung Cancer. 95, p. 73-81 9 p.

Research output: Contribution to journalArticle

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.

Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D. L., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C., Filipazzi, V., Menis, J. & 8 others, Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Bria, E., Spitaleri, G., Rossi, A. & Novello, S., May 1 2016, In : Lung Cancer. 95, p. 73-81 9 p.

Research output: Contribution to journalArticle

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.

Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C., Filipazzi, V., Menis, J. & 8 others, Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Bria, E., Spitaleri, G., Rossi, A. & Novello, S., May 1 2016, In : Lung Cancer. 95, p. 73-81 9 p.

Research output: Contribution to journalArticle

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients. Results from a multicenter Italian observational study.

Vavalà, T., Follador, A., Tiseo, M., Galetta, D., Morabito, A., Di Maio, M., Martelli, O., Caffo, O., Piovano, P. L., Cortinovis, D. L., Zilembo, N., Casartelli, C., Banna, G. L., Ardizzoia, A., Barzelloni, M. L., Bearz, A., Genestreti, G., Mucciarini, C., Filipazzi, V., Menis, J. & 8 others, Rizzo, E., Barbieri, F., Rijavec, E., Cecere, F., Bria, E., Spitaleri, G., Rossi, A. & Novello, S., May 1 2016, In : Lung Cancer. 95, p. 73-81 9 p.

Research output: Contribution to journalArticle